The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $56.81

Today's change-0.40 -0.70%
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $56.81

Today's change-0.40 -0.70%
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.

Molina Healthcare Inc down (U.S.)$0.40

Molina Healthcare Inc closed lower Friday, dropping (U.S.)$0.40 or 0.70% to (U.S.)$56.81. Over the last five days, shares have gained 7.11%, but are down 5.52% for the last year to date. Shares have underperformed the S&P 500 by 20.55% during the last year.

Key company metrics

  • Open(U.S.) $56.76
  • Previous close(U.S.) $57.21
  • High(U.S.) $57.29
  • Low(U.S.) $56.07
  • Bid / Ask-- / --
  • YTD % change-5.52%
  • Volume1,113,140
  • Average volume (10-day)1,252,414
  • Average volume (1-month)1,073,416
  • Average volume (3-month)1,152,713
  • 52-week range(U.S.) $44.50 to (U.S.) $82.37
  • Beta1.71
  • Trailing P/E24.83×
  • P/E 1 year forward21.89×
  • Forward PEG1.22×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.29
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.82%

Based on its net profit margin of 0.82%, Molina Healthcare Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.21%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue4,3433,8713,6113,525
Total other revenue--------
Total revenue4,3433,8713,6113,525
Gross profit628568561563
Total cost of revenue3,7153,3033,0502,962
Total operating expense4,2543,7943,4993,409
Selling / general / administrative507463423422
Research & development--------
Depreciation / amortization32282625
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income8976113116
Interest income (expense), net non-operating-25-21-15-15
Gain (loss) on sale of assets--------
Other--------
Income before tax645698101
Income after tax24304639
Income tax, total40275162
Net income24304639
Total adjustments to net income--------
Net income before extra. items24304639
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items24304639
Inc. avail. to common incl. extra. items24304639
Diluted net income24304639
Dilution adjustment--------
Diluted weighted average shares57606050
Diluted EPS excluding extraordinary itemsvalue per share0.420.490.770.77
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.420.490.770.77